Radiotherapy Clinical Trials in Beijing
11 recruitingBeijing, China
Showing 1–11 of 11 trials
Recruiting
Phase 3
Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC
Radiotherapy, AdjuvantHepatocellular Carcinoma (HCC)Immune Checkpoint Inhibitor+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences286 enrolled1 locationNCT07186621
Recruiting
Phase 2
A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma (Icc)Adjuvant ChemoradiotherapyNarrow Margin+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences66 enrolled1 locationNCT07063888
Recruiting
Phase 2
Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer
Esophageal CancerSurgeryImmunotherapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences60 enrolled3 locationsNCT06421376
Recruiting
Phase 3
Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer
Cervical CancerAdaptive Radiotherapy
Peking Union Medical College Hospital440 enrolled1 locationNCT06641635
Recruiting
Phase 2
Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer
Cervical CancerPET/CTRadiotherapy+2 more
Peking Union Medical College Hospital51 enrolled1 locationNCT06353061
Recruiting
Phase 1Phase 2
Chemoradiotherapy in Unresectable Esophageal Cancer
Esophageal CancerChemoradiotherapyAlbumin-bound Paxlitaxel+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences105 enrolled5 locationsNCT04278287
Recruiting
Phase 2
Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients
Non-small Cell Lung CancerConsolidation ImmunotherapyRadiotherapy or Sequential Chemoradiation
Peking University Cancer Hospital & Institute20 enrolled1 locationNCT05758116
Recruiting
Phase 2
Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients
Esophageal CancerChemotherapyImmunotherapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences55 enrolled1 locationNCT06429839
Recruiting
Phase 2
Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma
Esophageal CancerChemotherapyImmunotherapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences53 enrolled1 locationNCT06410651
Recruiting
Phase 2
Phase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.
Hepatocellular CarcinomaRadiotherapyNarrow Margin
Cancer Institute and Hospital, Chinese Academy of Medical Sciences100 enrolled1 locationNCT06205472
Recruiting
Phase 2
Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
Breast CancerRadiotherapy Side Effect
Cancer Institute and Hospital, Chinese Academy of Medical Sciences65 enrolled1 locationNCT05762900